5 things to watch on the ASX 200 on Tuesday

A better day of trade is expected for Aussie investors today.

Smiling man with phone in wheelchair watching stocks and trends on computer

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a disappointing fashion. The benchmark index sank 1.2% to 8,191.9 points.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 expected to rebound

The Australian share market is expected to rebound slightly on Tuesday after a mixed start to the week in the United States. According to the latest SPI futures, the ASX 200 is poised to open the day 23 points or 0.3% higher. In late trade on Wall Street, the Dow Jones is up 0.6%, but the S&P 500 is down 0.15% and the Nasdaq is 0.8% lower.

Buy the Newmont shares

The team at Goldman Sachs thinks investors should be buying Newmont Corporation (ASX: NEM) shares. This morning, the broker has initiated coverage on the gold miner's shares with a buy rating and $76.20 price target. This implies potential upside of almost 20% over the next 12 months. It said: "Newmont has one of the strongest EBITDA growth outlooks amongst our Australian gold coverage on a medium-term view on the back of production improvements across new and existing projects, further supported by gold pricing strength."

Oil prices jump

It could be a great session for ASX 200 energy shares Santos Ltd (ASX: STO) and Karoon Energy Ltd (ASX: KAR) on Tuesday after oil prices jumped overnight. According to Bloomberg, the WTI crude oil price is up 3% to US$78.88 a barrel and the Brent crude oil price is up 1.5% to US$80.98 a barrel. This was driven by expectations that Chinese and Indian supplies could be hit by Russian sanctions.

Telix beats guidance

Telix Pharmaceuticals Ltd (ASX: TLX) shares will be on watch today after the ASX 200 biotech stock beat its guidance for FY 2024. After the market close, the company revealed that FY 2024 unaudited revenue is approximately US$517 million (A$783 million). This exceeds its previously stated guidance of US$490 million to US$510 million, representing a 55% increase over FY 2023.

Gold price falls

ASX 200 gold miners including Bellevue Gold Ltd (ASX: BGL) and Regis Resources Limited (ASX: RRL) could have a poor session on Tuesday after the gold price tumbled overnight. According to CNBC, the gold futures price is down 1.3% to US$2,678.6 an ounce. A stronger US dollar put pressure on the precious metal.

Motley Fool contributor James Mickleboro has positions in Telix Pharmaceuticals. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group and Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A group of people push and shove through the doors of a store, trying to beat the crowd.
Broker Notes

2 ASX shares highly recommended to buy: Experts

Are these two stocks the best buys on the ASX?

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Broker Notes

These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Dividend Investing

I'd buy 5,883 shares of this ASX stock to aim for $1,000 of annual passive income

I’d pick this stock for its strong dividend record.

Read more »

A player pounces on the ball in the scoring zone of the field.
Best Shares

4 ASX 300 shares that ripped 100% or more in 2025

The S&P/ASX 300 Index rose 7.17% and delivered a total return, including dividends, of 10.66% in 2025.

Read more »

A little girl is about to launch down the slide with a blue sky and white clouds in the sky behind her.
Broker Notes

BHP vs. Fortescue shares: Goldman Sachs says 1 will rip and 1 will dip

Top broker Goldman Sachs upgraded its 12-month share price forecasts for BHP and Fortescue shares this week.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Brokers rate these 3 ASX shares as buys in January

These ASX shares have an exciting outlook according to experts.

Read more »

A young man sits at his desk working on his laptop with a big smile on his face.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why Australian Ethical, Northern Minerals, PLS, and Woodside shares are falling today

These shares are ending the week in the red. But why?

Read more »